Delivery Order SPE2DR25D2101-SPE2DR26F46HS
- Not listed
- The Defense Logistics Agency awarded a $5,250.31 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Fomepizole 1.5 GM/1.5 ML vials. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen will perform the delivery from its Conshohocken, Pennsylvania location, with an ultimate completion date of December 24, 2025. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,887.94 delivery order to AmerisourceBergen Drug Corp for the supply of Fomepizole 1.5 gm/1.5 ml vials on July 21, 2025, with an ultimate completion date of July 22, 2025. The award is structured as a firm fixed-price contract with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fomepizole 1.5 GM/1.5 ML vials. The $2,887.34 firm-fixed-price contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,252.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1.5 gram/1.5 milliliter vials of the drug fomepizole. This single award contract has a completion date of February 8, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,054.28 Firm Fixed Price Delivery Order is for the supply of 4566682365 FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, with a final delivery date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The Defense Logistics Agency Troop Support Medical awarded a $833 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1.5 gram/1.5 milliliter vials of fomepizole. Performance will take place in Conshohocken, Pennsylvania under a contract vehicle held by Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation. The delivery order is for a single pharmaceutical product to support DLA Troop Support Medical programs. No subcontractors or set aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $134,890.92 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.77 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of December 1, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $193,492.64 to AmerisourceBergen Drug Corp on December 8, 2025, with a completion date of December 9, 2025. This non-competitive, firm fixed price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a...
- The Defense Logistics Agency awarded a delivery order valued at $13,430.85 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 24, 2025, represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46HSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,383.85 to AmerisourceBergen Drug Corp for the supply of Fomepizole 1.5 GM/1.5 ML vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price contract represents a non-competitive delivery order placed under an existing indefinite delivery vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a critical federal vendor, AmerisourceBergen maintains an extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's selection as a prime vendor reflects its demonstrated capability to meet federal procurement requirements and supply diverse medical commodities across multiple therapeutic domains in support of military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/9/25 |